WSAUA Annual MeetingOctober 24 - 29, 2009
Las Vegas, NV
Prostate Cancer Information for Patients and Loved Ones
Patients and families affected by prostate cancer may find important information about the disease in a series of videos by the Outreach Program of the Moores UCSD Cancer Center.
To watch the videos or read the transcripts, click here.
As a leader in research and patient care, the UCSD Division of Urology is committed to providing the latest in expert and compassionate treatment, performing cutting-edge research, and training the next generation of top urologists. We are currently ranked among America's best hospitals in the field of Urology by U.S. News & World Report.
UCSD is a young institution but it has quickly become one of the most successful scientific universities in the world. In collaboration with the UCSD Medical Center and School of Medicine, the Division of Urology’s new strategic focus is clinical excellence. With research programs that command international respect and consistently rank among the top 20 in NIH funding, we are well positioned to elevate our clinical programs to the same world-class status. Our surgeons are skilled in the full range of urologic surgical procedures, from the latest minimally invasive techniques, including robotic prostatectomy, to extensive reconstructive surgeries for genitourinary cancers and trauma. Our debut on the specialty rankings of U.S. News & World Report this year marks the successful launch of our new initiative.
The Division’s clinical and research facilities, divided among three locations, serve a broad mix of patients over a 9,000 square mile area. The UCSD Medical Center and University Hospital are located in the central city area of San Diego; the John and Rebecca Moores Comprehensive Cancer Center is located approximately twelve miles north in La Jolla; and the John M. and Sally B. Thornton Hospital is adjacent to the Cancer Center. Please visit our Procedures page for information about the special services, procedures, and treatments we offer.
Saturday, July 25
The next Quarterly Urology Grand Rounds will be held on Saturday, July 25, from 7:30 am to 11:00 am at the main auditorium at the Hillcrest Medical Center.
UCSD School of Medicine designates this activity for a maximum of one credit per hour of AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.
For further information, contact Joy Dinius (jdinius@ucsd.edu; 619-543-2659).
See all upcoming urology meeting dates and abstract deadlines
Breaking New Ground in Kidney Cancer Surgery
A team of surgeons led by Dr. Ithaar Derweesh recently performed a complex, single-incision surgery to remove a kidney tumor while preserving and then reconstructing the remaining healthy kidney. The UCSD team is the second in the world to perform this procedure. Read more.
Another groundbreaking surgery was performed on February 5, when UCSD surgeons removed a cancerous kidney through a single incision in the patient's navel. This procedure was the first of its kind in California. Read more.
2009 Paul Zimskind Award
The Society for Urodynamics and Female Urology presented this year's Paul Zimskind Award to Dr. Michael Albo in recognition of his continuing excellence and leadership in the field of voiding dysfunction.
AUA Guideline for Management of the Clinical Stage 1 Renal Mass
The first-ever official AUA guideline on the management of early-stage renal masses was released on April 28. The guideline, whose authorship committee includes UCSD's Ithaar Derweesh, favors nephron-sparing treatments such as partial nephrectomy over radical nephrectomy for stage 1 kidney tumors.
Urologic Oncology Fellowship
The Division welcomes Dr. Sean Stroup, who will begin his urologic oncology fellowship with us this September.
2009 AUA Match Results
Congratulations to the newest residents to match with UCSD Urology: Hossein Mirheydar, of the University of Minnesota Medical School, and Jason Woo, from the University of Chicago Pritzker School of Medicine. Hossein and Jason will begin their training in urology after a two-year residency in general surgery.
New Drug Provides Hope for Sufferers of Interstitial Cystitis
A new patent has been issued for an experimental drug therapy developed by Dr. C. Lowell Parsons. The drug therapy, which has yielded positive results in a recent Phase 2 study, is a combination of an anesthetic and heparin delivered directly into the bladder via a catheter. The anesthetic provides rapid pain relief while heparin restores the protective mucus layer of the bladder. Read more.